Organisation · Unternehmen
Valneva
valneva-eutr-04057075
Aussagen (8)
eu transparency category
Companies & groups
dokumentiert
[Q-19645]
eu transparency goals
Valneva is a specialty vaccine company focused on prevention against diseases with major unmet needs. The Company has several vaccines in development including vaccines against Lyme disease and Zika. Valneva’s portfolio includes three commercial vaccines for travelers: IXCHIQ® for the prevention of disease caused by chikungunya virus (CHIKV), IXIARO®/JESPECT® indicated for the prevention of Japanese encephalitis and DUKORAL® indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by ETEC.
dokumentiert
[Q-19645]
eu transparency id
116284040570-75
dokumentiert
[Q-7535]
headquarters city
Lyon
dokumentiert
[Q-19645]
headquarters country
FR
dokumentiert
[Q-19645]
interest class
business_company
dokumentiert
[Q-29773]
legal form
SE
dokumentiert
[Q-19645]
legal form class
unbekannt
berichtet
[Q-29775]